Parnax Lab Ltd

Parnax Lab Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Parnax Lab Ltd

₹ 97.0 -2.04%
01 Dec - close price
naxparlab.com BSE: 506128
About

Incorporated in 1985, Parnax Lab Ltd manufactures and exports Pharmaceutical Formulations[1]

Key Points

Business Overview:[1][2]
PLL is a part Naxpar Group and is a WHO-approved and EHS-compliant Company. It is into contract manufacturing of Liquid Orals, Capsules, Ointments, External Powders & Tablets with its manufacturing facility located
at Silvassa.

Website BSE
  • Market Cap ₹ 111 Cr.
  • Current Price ₹ 97.0
  • High / Low ₹ 110 / 47.1
  • Stock P/E 11.4
  • Book Value ₹ 58.6
  • Dividend Yield 0.00 %
  • ROCE 14.8 %
  • ROE 15.9 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 50.1% CAGR over last 5 years

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 13.0% over last 3 years.
  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023
26.75 24.83 20.48 28.69 35.75 50.68 47.91 36.74 43.14 46.82 40.91 48.74 42.61
21.80 22.18 20.80 25.33 30.20 43.57 40.90 31.43 37.58 39.44 36.18 42.24 37.32
Operating Profit 4.95 2.65 -0.32 3.36 5.55 7.11 7.01 5.31 5.56 7.38 4.73 6.50 5.29
OPM % 18.50% 10.67% -1.56% 11.71% 15.52% 14.03% 14.63% 14.45% 12.89% 15.76% 11.56% 13.34% 12.41%
0.06 0.03 0.09 0.04 0.07 0.02 0.21 0.12 0.30 0.08 0.27 0.24 0.22
Interest 1.30 1.27 1.27 1.17 1.44 1.25 1.37 1.26 1.20 1.30 1.18 1.16 1.43
Depreciation 1.31 1.29 1.33 1.26 1.30 1.31 2.00 1.66 1.55 1.74 1.59 1.60 1.74
Profit before tax 2.40 0.12 -2.83 0.97 2.88 4.57 3.85 2.51 3.11 4.42 2.23 3.98 2.34
Tax % 0.00% 0.00% -9.89% 0.00% 0.00% 0.00% 104.16% 23.11% 32.48% 28.51% 35.43% 16.33% 20.09%
2.40 0.12 -3.11 0.97 2.88 4.56 -0.15 1.93 2.10 3.16 1.44 3.33 1.87
EPS in Rs 2.82 0.14 -3.64 1.14 3.37 5.35 -0.15 1.97 1.83 2.74 1.25 2.89 1.63
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
94 58 70 103 71 95 106 109 95 90 163 168 179
94 50 62 91 61 82 95 99 89 80 140 145 155
Operating Profit 0 7 8 12 10 13 10 10 6 10 23 23 24
OPM % 0% 13% 12% 12% 14% 14% 10% 9% 7% 11% 14% 14% 13%
1 1 1 1 1 0 1 2 1 0 0 1 1
Interest 4 4 4 4 4 5 4 4 5 5 5 5 5
Depreciation 2 2 2 3 3 4 4 4 4 5 6 7 7
Profit before tax -5 3 3 5 3 5 3 5 -2 -0 12 12 13
Tax % 46% 35% 27% 22% 28% 22% 65% 28% -48% -350% 33% 30%
-3 2 2 4 3 4 1 3 -3 -0 8 9 10
EPS in Rs -3.29 2.01 2.93 5.01 2.95 4.33 1.23 3.88 -3.42 -0.42 8.40 7.51 8.51
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 11%
5 Years: 10%
3 Years: 21%
TTM: 0%
Compounded Profit Growth
10 Years: 18%
5 Years: 50%
3 Years: 71%
TTM: 16%
Stock Price CAGR
10 Years: 7%
5 Years: 16%
3 Years: 50%
1 Year: 29%
Return on Equity
10 Years: 10%
5 Years: 9%
3 Years: 13%
Last Year: 16%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 8 8 8 8 8 8 8 8 8 8 10 11 11
Reserves 10 10 12 17 19 23 24 27 24 24 37 51 56
29 27 33 41 42 39 37 42 51 59 69 55 59
14 15 29 17 10 15 18 17 23 15 38 28 31
Total Liabilities 61 60 83 83 79 86 87 95 107 106 153 145 158
33 33 36 36 38 47 44 51 58 60 72 77 89
CWIP 0 0 1 1 2 0 0 0 3 5 3 2 0
Investments 1 1 1 1 1 0 0 0 0 0 0 0 0
26 27 46 45 38 38 43 43 46 41 78 66 68
Total Assets 61 60 83 83 79 86 87 95 107 106 153 145 158

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
1 6 -0 -0 3 16 13 9 9 6 9 21
-1 -1 -6 -4 -6 -10 -5 -11 -13 -7 -16 -10
-1 -3 6 6 1 -5 -7 1 5 0 12 -14
Net Cash Flow -1 1 0 1 -2 0 1 -1 0 -0 4 -3

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 44 87 130 84 100 72 65 64 88 68 85 61
Inventory Days 32 72 143 38 64 50 45 52 76 80 73 79
Days Payable 62 104 203 51 30 48 45 44 74 46 81 53
Cash Conversion Cycle 14 55 71 71 134 74 64 72 90 102 77 86
Working Capital Days 23 43 75 59 74 34 44 53 77 103 73 67
ROCE % 14% 15% 16% 11% 14% 11% 12% 3% 6% 17% 15%

Shareholding Pattern

Numbers in percentages

Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
62.59% 62.59% 62.59% 62.59% 62.59% 67.58% 67.58% 72.30% 72.30% 72.30% 72.30% 72.30%
37.41% 37.41% 37.41% 37.41% 37.41% 32.42% 32.42% 27.71% 27.71% 27.70% 27.69% 27.69%
No. of Shareholders 2,1952,1052,2072,1392,2592,4032,6053,0963,0703,0603,2213,543

Documents

Announcements

Annual reports

Credit ratings